328 related articles for article (PubMed ID: 15918165)
1. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
[TBL] [Abstract][Full Text] [Related]
4. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
Petersen E; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333
[TBL] [Abstract][Full Text] [Related]
6. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
Manabe T; Imoto K; Uchida K; Doi C; Takanashi Y
Surg Today; 2004; 34(3):220-5. PubMed ID: 14999533
[TBL] [Abstract][Full Text] [Related]
7. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
LeMaire SA; Wang X; Wilks JA; Carter SA; Wen S; Won T; Leonardelli D; Anand G; Conklin LD; Wang XL; Thompson RW; Coselli JS
J Surg Res; 2005 Jan; 123(1):40-8. PubMed ID: 15652949
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
Eliason JL; Hannawa KK; Ailawadi G; Sinha I; Ford JW; Deogracias MP; Roelofs KJ; Woodrum DT; Ennis TL; Henke PK; Stanley JC; Thompson RW; Upchurch GR
Circulation; 2005 Jul; 112(2):232-40. PubMed ID: 16009808
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
[TBL] [Abstract][Full Text] [Related]
12. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
Xiong W; Knispel R; Mactaggart J; Baxter BT
J Vasc Surg; 2006 Nov; 44(5):1061-6. PubMed ID: 17098543
[TBL] [Abstract][Full Text] [Related]
13. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
Ishii T; Asuwa N
Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
[TBL] [Abstract][Full Text] [Related]
16. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Wilson WR; Evans J; Bell PR; Thompson MM
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
[TBL] [Abstract][Full Text] [Related]
18. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture.
Mao D; Lee JK; VanVickle SJ; Thompson RW
Biochem Biophys Res Commun; 1999 Aug; 261(3):904-10. PubMed ID: 10441523
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion.
Lamparter S; Schoppet M; Christ M; Pankuweit S; Maisch B
Am J Cardiol; 2005 May; 95(9):1065-9. PubMed ID: 15842972
[TBL] [Abstract][Full Text] [Related]
20. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?
van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
